Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

Compare

1.580

-0.130 (-7.60%)

At close: Feb 17, 2026, 4:00 PM EST

1.580

0.00 (0.02%)

After-hours: Feb 17, 2026, 5:57 PM EST

PACB Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	160.01	154.01	200.52	128.3	130.51
Revenue Growth (YoY)	3.89%	-23.19%	56.29%	-1.69%	65.43%
Cost of Revenue	105.15	106.34	142.32	74.83	71.35
Gross Profit	54.85	47.67	58.2	53.47	59.17
Selling, General & Admin	141.49	175.02	169.82	160.85	124.12
Research & Development	97.31	134.92	187.17	193	112.9
Amortization of Goodwill & Intangibles	369.44	27.4	8.14	0.73	0.31
Other Operating Expenses	4.18	1	3.44	3.71	-
Operating Expenses	612.41	338.34	368.56	358.29	237.33
Operating Income	-557.56	-290.66	-310.37	-304.82	-178.16
Interest Expense	-6.95	-13.41	-14.34	-14.69	-12.53
Other Non Operating Income (Expenses)	14.76	10.74	19.84	7.39	4.1
EBT Excluding Unusual Items	-549.76	-293.34	-304.86	-312.12	-186.59
Merger & Restructuring Charges	-	-	-9.04	-	-83.13
Impairment of Goodwill	-93.2	-144.5	-	-	-
Gain (Loss) on Sale of Investments	-	13.04	12.84	0.24	-4.01
Asset Writedown	78.2	-40	-	-	-
Other Unusual Items	18.7	155.26	-17.09	-2.38	-1.14
Pretax Income	-546.06	-309.54	-318.16	-314.25	-274.87
Income Tax Expense	0.32	0.32	-11.42	-	-93.65
Net Income	-546.38	-309.85	-306.74	-314.25	-181.22
Net Income to Common	-546.38	-309.85	-306.74	-314.25	-181.22
Shares Outstanding (Basic)	300	274	254	225	204
Shares Outstanding (Diluted)	300	274	254	225	204
Shares Change (YoY)	9.28%	8.22%	12.95%	10.00%	16.67%
EPS (Basic)	-1.82	-1.13	-1.21	-1.40	-0.89
EPS (Diluted)	-1.82	-1.13	-1.21	-1.40	-0.89
Free Cash Flow	-	-212.25	-268.02	-279.96	-117.11
Free Cash Flow Per Share	-	-0.77	-1.06	-1.25	-0.57
Gross Margin	34.28%	30.95%	29.02%	41.68%	45.33%
Operating Margin	-348.46%	-188.73%	-154.78%	-237.58%	-136.51%
Profit Margin	-341.47%	-201.18%	-152.97%	-244.93%	-138.85%
Free Cash Flow Margin	-	-137.81%	-133.66%	-218.20%	-89.73%
EBITDA	-52.65	-249.48	-290.64	-294.43	-170.58
EBITDA Margin	-32.91%	-161.98%	-144.94%	-229.47%	-130.70%
D&A For EBITDA	504.91	41.19	19.72	10.39	7.58
EBIT	-557.56	-290.66	-310.37	-304.82	-178.16
EBIT Margin	-	-188.73%	-154.78%	-237.58%	-136.51%
Revenue as Reported	160.01	154.01	200.52	128.3	130.51

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q